Publication

Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study

Downloadable Content

Persistent URL
Last modified
  • 06/25/2025
Type of Material
Authors
    Gilbert H.L. Tang, Mount Sinai Health SystemJulianne Spencer, Medtronictoby Rogers, MedStar Washington Hospital CenterKendra Grubb, Emory UniversityPatrick Thomas Gleason, Emory UniversityHemal Gada, University of PittsburghPaul Mahoney, Sentara Heart HospitalHarold L. Dauerman, University of VermontJohn K. Forrest, Yale UniversityMichael J. Reardon, Houston MethodistPhilipp Blanke, University of British ColumbiaJonathon A. Leipsic, University of British columbiaMohamed Abdel-Wahab, University of LeipzigGuilherme Attizzani, University Hospitals Cleveland Medical CenterRishi Puri, Cleveland ClinicMichael Caskey, Abrazo Arizona Heart HospitalChristine J. Chung, University of Washington, SeattleYing-Hwa Chen, Taipei Veterans General HospitalDariusz Dudek, Jagiellonian UniversityKeith B. Allen, St. Luke's Mid America Heart InstituteAdnan K. Chhatriwalla, St. Luke's Mid America Heart InstituteWah Wah Htun, Gundersen Health SystemDaniel J. Blackman, Leeds Teaching HospitalsGiuseppe Tarantini, University of PaduaJorge Zhingre Sanchez, MedtronicGreta Schwartz, MedtronicJeffrey J. Popma, MedtronicJanarthanan Sathananthan, University of British Columbia
Language
  • English
Date
  • 2023-11-21
Publisher
  • Wolters Kluwer
Publication Version
Copyright Statement
  • © 2023 The Authors.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 16
Issue
  • 11
Start Page
  • e013238
Grant/Funding Information
  • This work was supported by Medtronic, United States.
Supplemental Material (URL)
Abstract
  • BACKGROUND: Coronary accessibility following redo–transcatheter aortic valve replacement (redo-TAVR) is increasingly important, particularly in younger low-risk patients. This study aimed to predict coronary accessibility after simulated Sapien-3 balloon-expandable valve implantation within an Evolut supra-annular, self-expanding valve using pre-TAVR computed tomography (CT) imaging. METHODS: A total of 219 pre-TAVR CT scans from the Evolut Low-Risk CT substudy were analyzed. Virtual Evolut and Sapien-3 valves were sized using CT-based diameters. Two initial Evolut implant depths were analyzed, 3 and 5 mm. Coronary accessibility was evaluated for 2 Sapien-3 in Evolut implant positions: Sapien-3 outflow at Evolut node 4 and Evolut node 5. RESULTS: With a 3-mm initial Evolut implant depth, suitable coronary access was predicted in 84% of patients with the Sapien-3 outflow at Evolut node 4, and in 31% of cases with the Sapien-3 outflow at Evolut node 5 (P<0.001). Coronary accessibility improved with a 5-mm Evolut implant depth: 97% at node 4 and 65% at node 5 (P<0.001). When comparing 3- to 5-mm Evolut implant depth, sinus sequestration was the lowest with Sapien-3 outflow at Evolut node 4 (13% versus 2%; P<0.001), and the highest at Evolut node 5 (61% versus 32%; P<0.001). CONCLUSIONS: Coronary accessibility after Sapien-3 in Evolut redo-TAVR relates to the initial Evolut implant depth, the Sapien-3 outflow position within the Evolut, and the native annular anatomy. This CT-based quantitative analysis may provide useful information to inform and refine individualized preprocedural CT planning of the initial TAVR and guide lifetime management for future coronary access after redo-TAVR.
Author Notes
  • Correspondence: Janarthanan Sathananthan, MBChB, MPH, St. Paul’s Hospital, 1081 Burrard St, Vancouver, British Columbia V6Z 1Y6, Canada, Email jsathananthan@providencehealth.bc.ca
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items